Hence, our findings elucidated a novel mechanism whereby the PROS1-AXL axis induced the secretion of MMP9 from macrophages, thereby providing valuable insights and supporting the therapeutic application of AXL inhibition in HCC. The gene discussed is MMP9; the disease is hepatocellular carcinoma.